ArticleAir quality, atmosphere, & health2026
PAH-associated health risk from ultrafine particles: an urban field study.
Article in Air quality, atmosphere, & health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Ultrafine particles (UFPs) are airborne particulate matter with diameters less than 100 nm. UFPs present in urban atmospheres pose a significant public health issue because they usually carry harmful substances, including toxic metals and polycyclic aromatic hydrocarbons (PAHs). Prolonged exposure to urban UFPs may result in cumulative deposition of these harmful substances in the human respiratory system, elevating the likelihood of adverse respiratory outcomes. Thus, studying UFP respiratory deposition is essential for assessing associated health risks. In this research, a set of field studies was conducted at three selected sampling sites to examine urban UFP exposure in the Greater Houston Area, Texas, USA. At each sampling site, UFP respiratory deposition measurements were performed using the Mobile Aerosol Lung Deposition Apparatus (MALDA). In addition, size-segregated UFP samples were collected and analyzed to identify and quantify harmful constituents associated with UFPs. The resulting data were used to estimate the deposited mass of PAH in human airways and to evaluate the corresponding health risks linked to urban UFP exposure. Overall, both non-carcinogenic and carcinogenic risks associated with UFP-bound PAH in the Greater Houston Area were found to remain within acceptable levels.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.